Synapse - Steven Horwitz

Results (664)

Results from a phase 1/2, open-label, dose-finding study of pralatrexate and oral bexarotene in patients with relapsed/refractory cutaneous T-cell lymphoma

Meeting Abstract

Duvic, M.; Horwitz, S. M.; Kim, Y. H.; Zinzani, P. L.; Bhat, G.; Sharma, P.; Yancik, S.
Blood (2015)

Fulltext@MSK | Save

Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay

Meeting Abstract

Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
Blood (2015)

Fulltext@MSK | Save

Frontline treatment of CD30+peripheral T-cell lymphomas with brentuximab vedotin in combination with CHP: 3-year durability and survival follow-up

Meeting Abstract

Horwitz, S. M.; Shustov, A. R.; Forero-Torres, A.; Bartlett, N. L.; Advani, R.; Pro, B.; Chen, R.; Davies, A. J.; Illidge, T.; Huebner, D.; more...
Blood (2015)

Fulltext@MSK | Save

High-depth, targeted, next generation sequencing identifies novel genetic alterations in cutaneous T-cell lymphoma

Meeting Abstract

Argyropoulos, K. V.; Horwitz, S. M.; Rapaport, F.; Velardi, E.; Myskowski, P.; Querfeld, C.; Pulitzer, M.; Dogan, A.; Gallagher, M.; Socci, N. D.; more...
Blood (2015)

Fulltext@MSK | Save

Physician-lymphoma survivor discussions of health promotion: A qualitative analysis

Meeting Abstract

Blanch-Hartigan, D.; Shuk, E.; McLarney, K.; Philip, E. J.; Horwitz, S.; Bylund, C.
Annals of Behavioral Medicine (2015)

Fulltext@MSK | Save

Zebras and hen's teeth: Recognition and management of rare T and NK lymphomas

Journal Article

Mehta-Shah, N.; Horwitz, S.
Hematology-American Society of Hematology Education Program (2015)

Fulltext@MSK | Save

Duvelisib (IPI-145), an oral dual inhibitor of PI3K-delta,gamma, is clinically active in patients with relapsed/refractory chronic lymphocytic leukemia

Meeting Abstract

O'Brien, S.; Patel, M.; Kahl, B.; Horwitz, S.; Foss, F.; Porcu, P.; McLaughlin, J.; Sweeney, J.; Allen, K.; Faia, K.; more...
Leukemia and Lymphoma (2015)

Fulltext@MSK | Save

Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)

Meeting Abstract

Phillips, A.; Fields, P.; Hermine, O.; Taylor, G. P.; Delioukina, M.; Horwitz, S.; Ramos, J. C.; Meniane, J. C.; Barta, S. K.; Brites, C.; more...
Retrovirology (2015)

Fulltext@MSK | Save

Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sézary syndrome with variable CD30 expression level: A multi-institution collaborative project